Staar Seeking Expedited Approval For Aqua-Flow Glaucoma Drainage Device
This article was originally published in The Gray Sheet
Executive SummaryAnticipated expedited review and subsequent FDA approval of Staar Surgical's Aqua-Flow collagen glaucoma drainage device would make it available for U.S. launch by the end of the year or early 2001, the firm projected during a March 30 teleconference.
You may also be interested in...
Civica Rx has won an investment of $55m through a deal with the Blue Cross Blue Shield Association of US health insurance firms to create a new subsidiary that will acquire and develop generic filings to be launched in the US from 2022.